Deorphanization and characterization of the ectopically expressed olfactory receptor OR51B5 in myelogenous leukemia cells

por Manteniotis, S, Wojcik, S, Göthert, J R, Dürig, J, Dührsen, U, Gisselmann, G, Hatt, H
Publicado 2016

Functional characterization of the ectopically expressed olfactory receptor 2AT4 in human myelogenous leukemia

por Manteniotis, S, Wojcik, S, Brauhoff, P, Möllmann, M, Petersen, L, Göthert, JR, Schmiegel, W, Dührsen, U, Gisselmann, G, Hatt, H
Publicado 2016

CHO(E)P-14 followed by alemtuzumab consolidation in untreated peripheral T cell lymphomas: final analysis of a prospective phase II trial

por Binder, C., Ziepert, M., Pfreundschuh, M., Dührsen, U., Eimermacher, H., Aldaoud, A., Rosenwald, A., Loeffler, M., Schmitz, N., Truemper, L.
Publicado 2013

Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma

por Eertink, J. J., Zwezerijnen, G. J. C., Heymans, M. W., Pieplenbosch, S., Wiegers, S. E., Dührsen, U., Hüttmann, A., Kurch, L., Hanoun, C., Lugtenburg, P. J., Barrington, S. F., Mikhaeel, N. G., Ceriani, L., Zucca, E., Czibor, S., Györke, T., Chamuleau, M. E. D., Hoekstra, O. S., de Vet, H. C. W., Boellaard, R., Zijlstra, J. M.
Publicado 2023